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Abstract
Background: Previous studies of T cell activation in dengue infection have focused on restriction of specific T cell
receptors (TCRs) and classical MHC molecules. However, bystander T cell activation, which is TCR independent,
occurs via cytokines in other viral infections, both in vitro and in vivo, and enables T cells to bypass certain control
checkpoints. Moreover, clinical and pathological evidence has pointed to cytokines as the mediators of dengue
disease severity. Therefore, we investigated bystander T cell induction by dengue viral antigen.
Results: Whole blood samples from 55 Thai schoolchildren aged 13-14 years were assayed for in vitro interferon-
gamma (IFN-g) induction in response to inactivated dengue serotype 2 antigen (Den2). The contribution of TCR-
dependent and independent pathways was tested by treatment with cyclosporin A (CsA), which inhibits TCR-
dependent activation of T cells. ELISA results revealed that approximately 72% of IFN-g production occurred via the
TCR-dependent pathway. The major IFN-g sources were natural killer (NK) (mean ± SE = 55.2 ± 3.3), CD4
+T (24.5 ±
3.3) and CD8
+T cells (17.9 ± 1.5), respectively, as demonstrated by four-color flow cytometry. Interestingly, in
addition to these cells, we found CsA-resistant IFN-g producing T cells (CD4
+T = 26.9 ± 3.6% and CD8
+T = 20.3 ±
2.1%) implying the existence of activated bystander T cells in response to dengue antigen in vitro. These bystander
CD4
+ and CD8
+T cells had similar kinetics to NK cells, appeared after 12 h and were inhibited by anti-IL-12
neutralization indicating cytokine involvement.
Conclusions: This study described immune cell profiles and highlighted bystander T cell activation in response to
dengue viral antigens of healthy people in an endemic area. Further studies on bystander T cell activation in
dengue viral infection may reveal the immune mechanisms that protect or enhance pathogenesis of secondary
dengue infection.
Background
T cell mediated production of cytokines, such as TNF-
alpha, interferon-gamma (IFN-g)a n di n t e r l e u k i n( I L ) -
10, has been reported to influence the severity of den-
gue infection [1-5]. The mechanisms of T cell activation
are mostly focused on the classical pathway, that is acti-
vation via binding of specific T cell receptors (TCRs)
and MHC molecules [6,7]. However, T cells may also
be activated after stimulation by ‘bystander’ or TCR-
independent signaling, for example by cytokines or
novel activating receptors [8-12]. Bystander T cell acti-
vation has been demonstrated in models of viral infec-
tion such as herpes simplex virus, LCMV and HIV
leading to proliferation of memory T cells and subse-
quent production of cytokines, which can induce pro-
tection or pathology [9,11,13]. In addition to virus
infection, our studies have identified IFN-g producing
bystander CD8
+T cells in response to intracellular bac-
teria and showed that these T cells produced IFN-g
within 24 h [10]. The mechanism of bystander IFN-g
activation depends on pro-inflammatory cytokines,
mainly IL-12 and IL-18 [14].
Dengue viral infection is the cause of dengue fever
(DF) and the more severe dengue hemorrhagic fever
(DHF) [15]. Secondary infection by dengue virus of dif-
ferent serotypes to the primary infection in children
aged less than 15 years is significantly associated with
severe DHF [16,17]. Previous studies have revealed that
a storm of pro-inflammatory cytokines is released dur-
ing acute infection [18]. These observations suggest that
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dengue infection.
In this study, we aimed to investigate the existence of
bystander T cell activation in healthy children living in
endemic areas who might be vulnerable to reinfection
with dengue virus and at risk of developing DHF [16].
We examined IFN-g production, which is the established
indicator for bystander T cell activation [10], after resti-
mulating with inactivated dengue viral antigens in vitro.
Bystander T cell activity was demonstrated by resistance
to cyclosporin A (CsA), which is a substance known to
inhibit T cell activation via the TCR-dependent pathway
[9,19,20] In addition, we described the kinetics of
bystander T cells and cytokines involved in IFN-
g-derived T cell activation. The description of immune
profiles in this study highlights bystander activation in
natural DV infection of healthy people in an endemic
area and emphasizes that the immune responses to
dengue virus are more complex than anticipated.
Results
Healthy Thai schoolchildren could produce IFN-g in
response to inactivated dengue virus serotype 2 in vitro
IFN-g was selected for determination as a marker of
bystander T cell function in this study. The mechanisms
of IFN-g production, triggered via TCR-dependent or
independent pathways, were investigated by treatment
with CsA, which is known to inhibit T cells via a TCR-
dependent pathway. Blood samples from 55 healthy
Thai schoolchildren aged 13-14 years were co-cultured
with control stimulators (medium, phytohemagglutinin
(PHA) and a combination of IL-12 plus IL-15 cytokines)
or Den2 in the absence or presence of CsA for 48 h.
The cultured supernatants were assayed for IFN-g by
sandwich ELISA.
The positive control stimulators induced significantly
higher IFN-g than the medium control (Figure 1A). In
this study, the reduction of IFN-g levels (as inhibited by
CsA) was defined as CsA sensitive or IFN-g triggered
via the TCR-dependent pathway, and CsA resistant
levels were defined as IFN-g triggered via the TCR-inde-
pendent pathway. As expected, in the control stimula-
tion, IFN-g induced by PHA, but not IL-12 plus IL-15,
was significantly inhibited by CsA treatment (P < 0.001,
Mann Whitney test) indicating that CsA sufficiently
inhibited IFN-g triggering via the TCR-dependent but
not the cytokine receptor dependent pathway. Interest-
ingly, IFN-g induced by Den2 stimulation was also sig-
nificantly inhibited by CsA (P < 0.001, Mann Whitney
test). Moreover, the remaining IFN-g levels after adding
CsA were also significantly higher than medium plus
CsA control (P < 0.001, Mann Whitney test).
Figure 1 IFN-g induction by inactivated dengue virus serotype 2 of 55 healthy Thai children aged 13-14 years. Whole blood samples
containing 9 × 10
5 lymphocytes/ml were co-cultured with medium alone, Den2, PHA and IL-12 plus IL-15 in the presence or absence of 0.3 μg/
ml cyclosporin A (CsA) for 48 h. The cultured supernatants were assayed for IFN-g by sandwich ELISA (A). Percentages of IFN-g inhibition as
calculated by CsA treatment (B). *** represents the statistically significant difference between the two groups (P < 0.0001, Mann Whitney test; NS
represents non significant).
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PHA and IL-12 plus IL-15 stimulation was 71.2 ± 2.9%
(mean ± SE), 73.2 ± 2.0% and 12.1 ± 2.7%, respectively
(Figure 1B). These results implied that IFN-g induction
by Den2 was mainly activated by the TCR-dependent
p a t h w a y( a p p r o x i m a t e l y7 0 % )a n dt oal e s s e rd e g r e eb y
TCR-independent signaling (approximately 30%).
To validate whether CsA does indeed inhibit all
TCR-stimulated IFN-g activation, a MHC class I-
restricted T cell epitope control of pooled peptides
(CEF) of cytomegalovirus, Epstein Barr virus and influ-
enza virus (Mabtech, AB, Sweden) was included in a
small study with five whole blood samples from
healthy school children stimulated with medium con-
trol, Den2, PHA and CEF in the presence or absence
of 0.3 μg/ml of CsA. The results clearly showed that
CsA could completely inhibit IFN-g induction by CEF
stimulation, but it partially inhibited IFN-g induced by
Den2. These results confirmed that CsA could inhibit
all IFN-g production from TCR-dependent activation
(See Additional file 1, Figure S1).
Moreover, we have previously titrated CsA concentra-
tion to test the ability of IFN-g inhibition. IFN-g induced
by PHA, which is the strongest IFN-g stimulator, was
inhibited by CsA in a dose-dependent manner and max-
imum inhibition occurred at 0.3 μg/ml of CsA and
remained constant at higher doses. This effect could be
detected at time points 4 and 42 h after incubation (See
Additional file 1, Figure S2). These results revealed that
CsA at this optimal concentration was able to inhibit
T activation, via TCR-dependent activation, in both
polyclonal and antigen-specific T cell activation.
Identification of IFN-g
+ cells that responded to Den2
To identify the types of immune cells that responded to
dengue virus in the presence or absence of CsA, the
intracellular sources of IFN-g were characterized by
four-color flow cytometry. Eighteen children who had
strong IFN-g responsiveness were followed up to deter-
mine the IFN-g producing cells. The collected whole
blood samples containing 9 × 10
5 lymphocytes/ml were
co-cultured with medium and 18 HA (hemagglutination)
units Den2 for 24 h in the absence or presence of CsA
prior to cell staining.
In flow cytometric analysis, total cell populations were
analyzed by side scatter and forward scatter plotting.
Then, the small lymphocyte population was first gated
and shown as region R1. Total IFN-g
+ cells were then
gated and shown as region R3 (Figure 2A). The types of
IFN-g
+ cells were then analyzed by the combination of
tri-CD3, FITC-CD8 and PE-CD4 or PE-CD56 and com-
pared in the presence and absence of CsA (Figure 2B).
The results revealed that Den2 stimulation induced
total %IFN-g
+ cells significantly higher than medium
controls, and approximately 43% (43.2 ± 6.0) were
inhibited by CsA (data not shown). Adding CsA resulted
in the reduction of total %IFN-g+ cells, and the propor-
tions of IFN-g
+ lymphocyte subsets were slightly chan-
ged (none statistically significant) by the decrease of
natural killer (NK) and increase of T cells. Moreover,
the results clearly demonstrated that some CD4
+ and
CD8
+T cells resisted the effect of CsA, suggesting that
dengue virus induces bystander T cell activation in vitro
(Figure 2B).
The IFN-g producing immune cell types in response
to Den2 stimulation consist of NK cells (mean ± SE =
55.2 ± 3.3%), CD4
+T (24.5 ± 3.3%) and CD8
+T (17.9 ±
1.5%) cells, respectively. Interestingly, the distribution of
CsA resistant or bystander CD4
+T cells ranged from 10
to 59% (mean ± SE = 26.9 ± 3.1%) and CD8
+T cells ran-
ged from 7 to 39% (20.3 ± 2.1%), respectively (Figure
2C). Of note, due to the shortage of blood samples in
this experiment, only 2 of 18 blood samples were stu-
died in the presence of CsA and stained for NK cells.
These results indicated that bystander (both CD4
+ and
CD8
+) T cells and NK cells could contribute equally to
the production of IFN-g in responses to dengue virus in
vitro.
The additional analysis of NK cell surface markers
clearly demonstrated that CD3-CD56+CD16+ cells were
also sources of IFN-g (23.9 ± 7.1% of NK cells) (data
not shown).
Kinetics of bystander T and NK cell activation
To describe characteristic of activated bystander T cells,
the kinetics of IFN-g production of those bystander T
cells were compared with innate NK cells and activated
specific T cells. Blood samples from seven schoolchil-
dren were studied after 12, 24 and 36 h stimulation
(details as described in the above section). The results
revealed that IFN-g
+ cells could be detected as early as
12 h and most of seven samples showed similar kinetics
of bystander CD4
+,C D 8
+Ta n dN Kc e l l s( F i g u r e3 A ) .
One particular sample (hC004) showed a CD8+T predo-
minant response with almost no CD4
+ T cells. These
results demonstrated the similar characteristics of
bystander T cells in producing IFN-g in addition to NK
cells in response to dengue virus. In contrast to bystan-
der CD4
+ and CD8
+T cells, specific CD4
+ and/or CD8
+T cells, were not detected as early as 12 h in five of
seven samples (hC004, hC022, hC031, hC038 and
hC084) (Figure 3B). The proportion of bystander and
specific T cells from 18 samples, however, was equal
after 24 h culture (Figure 3C). Taken together, these
results indicated that innate immune cells (NK cells and
bystander T cells) were rapidly induced in the early
response and were followed by specific T cells to pro-
duce IFN-g in response to dengue virus.
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Previously, proinflammatory cytokines such as IL-12,
IL-15 and IL-18 have been reported to elicit bystander
T cells to produce IFN-g [10,14]. To confirm that anti-
cytokine neutralizing antibodies are, in fact, capable of
inhibiting the cytokines at the concentrations used, the
whole blood samples from healthy donors were treated
with three-fold serial concentration of anti-IL-12, anti-
IL-15 and anti-IL-18 (at 0.3, 1 and 3 μg/ml, respectively)
for 15 minutes before stimulation with heat-inactivated
Burkholderia pseudomallei, a strong bystander or cyto-
kine-dependent T cell inducer as shown previously by
Figure 2 Identification of IFN-g producing cells using flow cytometry. Cells cultured with medium, Den2 with or without CsA at 24 h were
stained with tri-CD3, FITC-CD8 and PE-CD4 or PE-CD56 and APC-IFN-g. Gating profile of small lymphocyte (R1) and IFN-g
+ cell (R3) from one
representative sample (A). Gated IFN-g producing cells were analyzed with cell surface marker profiles (B). The distribution of IFN-g producing
CD4
+, CD8
+T and NK cells from 18 samples were plotted and compared between absence (-CsA) and presence of CsA (+CsA) (C) by Mann
Whitney test (NS represents non significant).
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harvested and examined for IFN-g level by ELISA. The
results showed that all three anti-cytokine neutralizing
antibodies could decrease IFN-g induction by B. pseudo-
mallei in a dose-dependent manner. Therefore, the con-
centration of these antibodies at 1 μg/ml was used in
the following Den2 experiments (See Additional file 1,
Figure S3).
To investigate these cytokines in IFN-g production in
response to dengue virus, the effects of neutralizing
antibodies to these cytokines were investigated. Eleven
whole blood samples from healthy adult blood donors
were studied by adding neutralizing monoclonal antibo-
dies to human IL-12, IL-15 and IL-18, and testing the
culture supernatants for IFN-g by ELISA. The results
revealed that adding anti-IL-12, but not anti-IL-15 nor
anti-IL-18, resulted in the statistically significant reduc-
tion of IFN-g in response to dengue virus stimulation.
These results revealed that IFN-g was mainly activated
by the IL-12-dependent pathway. Additionally, IFN-g
was completely inhibited by the combination of anti-IL-
12 and CsA treatment suggesting synergistic effects of
IL-12-dependent and TCR-dependent pathways (Figure
4A). Three representative donors were then selected to
characterize the intracellular sources of IFN-g by flow
cytometry using the protocol described above. The
results showed that, as for the blood samples from chil-
dren, the major IFN-g producing cells were NK, CD4
+T
and CD8
+T, respectively (data not shown). Additionally,
the distribution of bystander vs. specific CD4
+ or CD8
+T cells was not significantly different (Figure 4B).
To determine effect of neutralizing monoclonal antibo-
dies on the IFN-g producing subpopulation, two repre-
sentative samples were studied. Results showed that
anti-IL-12 and CsA could decrease IFN-g producing
cells derived from both CD4
+ and CD8
+Tc e l l sa n dt h e
synergistic effect of the two pathways was also observed.
CD4
+T cells were equally sensitive to anti-IL-12 and
CsA whereas CD8
+T cells were less sensitive to anti-IL-
12 than CsA (Figure 4C). In contrast to T cells, NK
cells were more sensitive to anti-IL-12 than CsA, as sug-
gested in one case where NK cell markers were included
and approximately 34% of IFN-g production from NK
cells was inhibited by CsA, while anti-IL-12 was able to
Figure 3 Kinetics of TCR signaling-specific vs. bystander IFN-g producing CD4
+T and CD8
+T cell subsets. The cultured cells from seven
representative samples were cultured with Den2 and analyzed the frequencies of IFN-g
+ CD4
+ or CD8
+ T cells in the presence of CsA (bystander
T cells) or NK cells at 12, 24 and 36 h (A). The kinetics of specific vs. bystander CD4
+ or CD8
+ T cells (B). The distributions of specific vs.
bystander CD4
+ or CD8
+ cells activated with Den2 for 24 h from 11 samples were compared using the Mann Whitney test (NS represents non
significant). The isotype controls were also stained and showed the background of % IFN-g producing cells less than 0.01%.
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firmed that there were bystander T cells that could pro-
duce IFN-g via an IL-12-dependent pathway in response
to dengue infection.
Discussion
In this study we first demonstrated that healthy Thai
schoolchildren could produce IFN-g in response to den-
gue virus serotype 2, which is the predominant serotype
and the major cause of DHF [16]. Then, we highlighted
the major finding that bystander CD4
+ Ta n dC D 8
+
T cells responding to dengue virus could account for
approximately 50% of immune components producing
IFN-g via the TCR-independent pathway as demon-
strated by their resistance to CsA (See Additional file 1,
Figure S4 for the details of calculation). The contribu-
tion of these innate and/or adaptive immune compo-
nents was demonstrated by the study of time kinetics,
and the results clearly showed that the kinetics of
bystander T cells were similar to those of NK cells and,
in most cases, were in contrast to specific T cells. These
results suggest a key function of innate immunity com-
posed of NK and bystander T cells in rapid responses to
control early dengue virus infection.
Determination of bystander T cell activation by using
CsA treatment has been previously used by our group
and others [9,21]. Moreover, the studies using neutraliz-
ing antibodies for IL-12, IL-15, IL-18 [14,19], or block-
ing antibodies for their receptors [21,22] has confirmed
that bystander T cells and NK cells could be activated
Figure 4 Effects of pro-inflammatory cytokine neutralizing antibodies on IFN-g production. Whole blood samples collected from 11
healthy donors were treated with monoclonal antibodies to IL-12, IL-15, IL-18 or CsA alone or in combination before adding inactivated Den2
for 48 h. IFN-g levels in all conditions were assayed and compared using the Wilcoxon matched pair test (***, * represent statistically significant
by P < 0.001 and P < 0.05, respectively; NS represents non significant) (A). Distribution of IFN-g producing bystander vs. specific induced by Den2
from three healthy adults were plotted and compared by using Mann Whitney test (B). IFN-g production by whole blood cells from one
representative healthy donor was induced by Den2 in the presence of 0.8 μg/ml anti-IL-12, CsA or a combination of anti-IL12 and CsA at the
time point of 24 h. IFN-g producing cells in each subpopulation were shown (C). ND represents not determined.
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that there were CD4
+ and CD8
+ T cells resistant to CsA
treatment in healthy children’s blood samples respond-
ing to dengue virus. These bystander T cells were
strongly activated via an IL-12-dependent pathway as
demonstrated by neutralization of anti-IL-12 but not
anti-IL-15 or anti-IL-18. Additionally, no synergistic
action between IL-12 and IL-15 or IL-18 could be
observed suggesting that the activation of T cells via IL-
12 alone was sufficient to produce IFN-g.P a g a n i net al.
have reported that IL-12 alone primes both CD4
+ and
CD8
+Tc l o n e sf o rh i g hI F N - g production, and the prin-
ciple mechanism is the ability to prime T cells during
Th1 clonal expansion [23]. In addition to IL-12 alone,
T cells also secrete IFN-g in a TCR-independent manner
after stimulation with the pro-inflammatory cytokines;
IL-12, IL-15 and IL-18 or the synergistic actions of IL-
12 and either IL-18 or IL-15 [24,25]. However, CsA
could inhibit some IFN-g producing NK cells. This
unexpected effect of CsA on NK cells has also been
demonstrated by Wang et al. The co-culture of periph-
eral blood NK cells subpopulations with CsA can
decrease proliferation of CD56
dim NK cells (CD3
-CD56
+CD16
+)b u tn o tC D 5 6
bright NK cells (CD3
-CD56
+CD16
-) [26]. Our studies have shown that CD56
dim NK
cells produced IFN-g in cell culture. Therefore, CsA
might affect this NK cell subpopulation.
In addition, CD16
-CD56
+ NK cells, CD3
-CD56
+CD16
+
NK cells, CD3
+CD56
+ NKT cells, CD3
-CD8
+ cells and
CD3
-CD4
+ cells were also found to produce IFN-g in
this study. Azeredo et al., have shown the increase of
CD3
-CD56
+CD16
+ (NK cells), CD3
+CD56
+ (CD56
+T
cells) during acute dengue infection [27]. Our findings
supported the idea that those cells could respond by
IFN-g production against dengue virus at least in an IL-
12-dependent manner. It has also been reported that
NK cells control early dengue virus infection via anti-
body-dependent cellular cytotoxicity [28]. In light of
recent evidence, the barrier between innate and adaptive
immunity seems to be blurred [29]; our study offers the
possibility of investigating this novel concept of host
immunity in dengue infection.
One study of immune responses of volunteers who
had received the live attenuated monovalent dengue
vaccines reported that restimulating memory CD4
+ T
cells in peripheral blood mononuclear cells with homo-
logous inactivated dengue serotype resulted in the high-
est IFN-g production whereas stimulation with
heterologous serotypes resulted in the alteration of IFN-
g to TNF-alpha production [30]. Another study from
the same group reported that dengue virus-reactive
CD8
+T cells showed differences in both proliferation
and cytokine production responding to heterologous
viral serotypes. Restimulation of these CD8
+ T cells with
dengue serotype 3 variant of NS4b epitope 2423 and
dengue 2 variant of NS4a epitope 2148 resulted in the
greatest cytokine production [31]. Moreover, Mongkol-
sapaya et al. have reported that cross-reactive dengue
specific CD8
+ T cells seemed to show suboptimal degra-
nulation but also high IFN-g and TNF-alpha production
[1]. These results implied that specific T cell responses
might lead to high levels of IFN-g production whereas
cross-reactive T cell responses alter cytokine profiles
and contribute to disease severity. In respect of our stu-
dies, IFN-g induced by Den1, 3 and 4 were also investi-
gated. However, the IFN-g induced by these antigens
was much less than Den2 stimulation. These results
might reflect the activation of Den2-specific T cells.
However, relative contribution of specific vs. cross-reac-
tive vs. bystander T cells to immunopathogenesis of
dengue infection requires further investigation.
Nevertheless, the pre-existing immunity which pro-
tects or increases disease severity during secondary
infection has not been well defined. The previous pro-
spective study of Thai schoolchildren has revealed that
t h eh i g h e rd e g r e eo fa c t i v a t i o no fp r e - e x i s t i n gI F N - g
responding to any of the four serotypes correlated with
the subsequent hospitalization of children aged 7-
10 years [5]. The IFN-g induction in our study generally
showed higher levels than the previous study of Man-
gada et al.; this could be due to the fact that all cellular
functions in our study were performed in whole blood
samples freshly collected within 4 h to avoid any
decreased activities by the cryopreservation process of
frozen samples. In addition, among 55 healthy school
children in this study, 11 were seronegative and 44 were
seropositive for IgG anti-dengue antibody. However,
bystander IFN-g production from these two populations
was not different. Thus the degree of total or bystander
IFN-g production may be further studied as a potential
predictor for DHF of sufficient severity to require
hospitalization.
This study focused on bystander IFN-g production in
responses to inactivated dengue viral antigens in vitro
using the same dengue viral preparation as for currently
available commercial antibody assays. Unfortunately, a
non-infected control from the same commercial source
was not available for confirmation of antigen specific
activation. Since it was prepared from suckling mouse
brain, no animal laboratories could provide the control
brain tissues without a proper license. Thus, IFN-g
induced by another source of inactivated antigens, cul-
tured supernatants of C6/36 mosquito cells infected
with dengue viral serotype 2 (16681 strain), was com-
pared instead (See Additional file 1, Figure S5). Inacti-
vated culture supernatants of mock-infected C6/36 cell
lines showed no IFN-g induction and the inactivated
supernatants of Den2-infected C6/36 cells could
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the medium control. Much less IFN-g was induced by
inactivated cultured supernatants than by mouse
extracts. However, regression analysis of IFN-g induced
by two antigens showed that bystander but not specific
IFN-g levels were correlated (See Additional file 1, Fig-
ure S6). These results strongly supported the observa-
tion that dengue antigens could trigger bystander IFN-g
production in vitro.
Conclusions
We have defined the bystander activation of T cells in
responses to dengue infection, mediated by IL-12-
dependent pathways existing in healthy Thai schoolchil-
dren. These bystander T cells play a major contribute to
the IFN-g production in response to dengue virus in
vitro. These immunological responses may be involved
in immunopathogenesis of dengue hemorrhagic fever
and provide basic information on immune cell profiles
in children living in endemic areas with potential use
for dengue vaccine development.
Methods
Subjects
The subjects were 55 healthy schoolchildren (17
females, 38 males, and aged 13-14 years) who were
studying at the Secondary School, Phu Wat Pittaya-
kom, Ubonrat District, Khon Kaen Province, Thailand.
Blood samples were collected from each child to
screen for IFN-g production using ELISA. Follow-up
blood samples were collected from 18 children for
characterization of intracellular IFN-g sources by four-
color flow cytometry. None of the children had had
any febrile episode in the seven days prior to collection
of the whole blood samples. Twelve children had pre-
viously been hospitalized because of dengue infection.
The protocol for the collection of whole blood samples
has been reviewed and approved by Khon Kaen Uni-
versity Ethics Committee for Human Research (project
number HE470510). All children and their parents
signed the informed consent form before whole blood
collection and the data in the consent forms were not
disclosed. Additionally, 11 blood samples were col-
lected from healthy adults to study cytokine neutraliza-
tion. The samples were processed using the same
protocol.
Stimulators
Control stimulators
The negative control was cell culture medium (10% fetal
bovine serum in RPMI). The positive controls for IFN-g
activation via the TCR-dependent pathway and cytokine
activation were 2.5 μg/ml PHA (Roche, USA) and
0.1 ng/ml IL-12 plus IL-15, respectively.
Dengue viral antigens
Lyophilized mouse brain extracts containing dengue
viral antigen serotype 1 (Den1, Hawaii strain), Den2 (Tr
1751 strain), Den3 (H 87 strain) and Den4 (H 241
strain) were purchased from the Department of Medical
Science, Ministry of Public Health, Thailand for use in
this study. These antigens were prepared by sucrose
acetone extraction of mouse brains infected by dengue
serotype 1-4 [32]. Preliminary studies revealed that 18
HA units of Den2 could induce the highest IFN-g pro-
duction compared to other serotypes. Thus this optimal
antigen concentration was used in all experiments.
Whole blood culture assay for IFN-g induction
Whole blood samples (18 ml) were collected from sub-
jects in heparinized tubes. Complete blood cells counts
were performed using an automatic analyzer (Sysmex
SF-3000, Germany). Lymphocyte numbers were adjusted
to 9 × 10
5 cells/ml by diluting with culture medium
(RPMI with 10% fetal bovine serum). The cells were
freshly co-cultured with stimulators in 96-well culture
plates and incubated in 5% CO2 at 37°C for 12, 24, 36,
and 48 h, or as required.
To distinguish the IFN-g production induced by TCR-
dependent and TCR-independent pathways, CsA (Sigma,
USA), a substance known to inhibit T cell activation via
the TCR-dependent pathway, was added at 0.3 μg/ml
which was the optimal concentration to inhibit IFN-g
production induced by PHA and then IFN-g levels was
compared in presence and absence of CsA [19,20].
For the cytokine neutralization assay, adjusted blood
samples were treated with 1 pg/ml of cytokine neutraliz-
ing monoclonal antibodies composed of anti-human IL-
12 (clone 24910.1, R&D system, USA), anti-IL-15
(clone34598.11, R&D system, USA), and anti-human IL-
18 (clone 125-2H, Medical & Biological Laboratories,
Japan) for 15 min before adding 18 HA units Den2. The
cultured supernatants were harvested and kept at -20°C
prior to IFN-g detection by sandwich ELISA (BD
OptEIA™ set Human IFN-g, BD Bioscience, USA) as per
manufacturer’s protocol. The standard curve was linear
up to 300 pg/ml and the detection limit was 18.8 pg/ml.
Any cultured supernatants that showed an optical den-
sity higher than 300 pg/ml were diluted, retested and
the IFN-g concentration was estimated by multiplying
with the dilution factor.
Intracellular IFN-g vs. cell surface markers staining and
flow cytometric analysis
Whole blood samples containing 9 × 10
5 lymphocytes/
ml were co-cultured with stimulators in FACS tubes
(BD Bioscience) and 10 μg/ml brefeldin A (Sigma) was
added for the last 3 h. Then, red blood cells in cultured
samples were lysed by lysing solution (BD Bioscience,
Suwannasaen et al. BMC Immunology 2010, 11:47
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Page 8 of 10USA), and the samples washed once with 1% FCS-PBS,
and Fc receptors were blocked with anti-CD16 for
30 min. Cultured cells were washed once and stained
for cell surface markers using tri-color labeled anti-CD3
(Caltag Laboratories, USA) and PE-labeled anti-CD4 or
PE-labeled anti-CD8 or PE-labeled-CD56 (PharMingen,
USA) and FITC-labeled anti-CD4 or FITC-labeled anti-
CD8 or FITC-labeled anti-CD16 (Caltag Laboratories).
Isotype-matched immunoglobulin controls were
included in each analysis. Staining of cell surface mar-
kers was performed for 30 min at 4°C, and the stained
cells were washed twice in cold 1% FCS-PBS and fixed
with 10% paraformaldehyde-PBS at 4°C for 15 min.
Fixation was followed by permeabilization with 1% FCS-
PBS, 0.1% saponin (Sigma) and 0.1% sodium azide
(Sigma). Staining of intracellular IFN-g was performed
by incubating permeabilized cells with 1 μg/tube APC-
labeled anti-human IFN-g (Caltag Laboratories) in incu-
bation buffer (1% FBS, 0.1% saponin and 0.1% sodium
a z i d ei nP B S )a tr o o mt e m p e r a t u r ef o r3 0m i n .T h e
stained cells were washed once and resuspended in 10%
paraformaldehyde-PBS. Analysis was performed by
FACSCalibur flow cytometer and CELLQuest software
(BD Bioscience).
Statistical analysis
The Mann-Whitney test and the Wilcoxon signed rank
test for comparison and linear regression for correlation
were performed using Graph Pad Prism software version
5 (GraphPad, San Diego, USA). A P-value less than 0.05
was considered statistically significant.
Additional material
Additional file 1: Supplement figures Figure S1: IFN-g production of
five healthy schoolchildren in responses to various stimulators. Figure
S2: Titration of cyclosporin A (CsA) to inhibit IFN-g induced by PHA.
Figure S3: Titrations of anti-IL-12, anti-IL-15 and anti-IL-18 to decrease
IFN-g induced by heat killed B. pseudomallei. Figure S4. Calculation of %
IFN-g producing CD4
+ or CD8
+T cells triggering via bystander and
specific T cell activation in responses to Den2. Figure S5: IFN-g induction
by inactivated dengue virus serotypes 2 prepared from mouse brain
extraction and cultured supernatants of C6/36 cell lines. Figure S6:
Linear regression analysis of IFN-g induction by inactivated dengue virus
serotypes 2 antigens prepared from mouse brain extraction and cultured
supernatants of C6/36 cell lines. Figure S7: Th1/Th2 cytokines induced
by Den2.
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Den: dengue viral antigen; Den1, 2, 3 and 4: dengue viral serotype 1, 2, 3
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interleukin; DHF: dengue hemorrhagic fever.
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